Is white cell reduction cost‐effective?

H. Perkins

DOI: https://doi.org/10.1046/j.1537-2995.1993.33893342741.x

1993-08-01

Transfusion

Abstract:The white cells (WBCs) contaminating routine red cell and platelet components serve no useful purpose, and the list of unwanted possible side effects of their transfusion keeps increasing.' Filters are now available that can remove approximately 3 log,, WBCs from these components,* and still more effective filters are being introduced. In view of these facts, suggestions have been made that all red cell and platelet components be filtered, on the grounds that harm is unlikely and some benefit is possible. A major obstacle to more general use of filters has been the added financial cost, coupled with uncertainty about the benefits. In this issue of TRANSFUSION, Balducci et al.3 present an argument that the use of filtered components may, in the long run, be financially less costly than that of unfiltered components, at least in adults with acute myelogenous leukemia. In the scenario of Balducci et al., filtered components save money because they will prevent or delay alloimmunization, thus reducing or eliminating the need for expensive platelet components selected by HLA matching or by crossmatching. Evidence that reducing the WBCs in transfused components minimizes refractoriness to random-donor platelet transfusions was first presented by Eernisse and Brand.4 More recent reports confirm that the presence of fewer than 5 x lo6 WBCs reduces alloimmunization and the development of a refractory state to platelet transfusi0n.l Currently available filters are capable of achieving these levels. Unfortunately, the evidence that WBC-reduced components can prevent the development of a refractory state is limited and somewhat inconsistent? and the proportion of patients who could benefit may be quite small.6 Moreover, 30 percent of patients who repeatedly undergo platelet transfusion never become alloimmunized,' and refractoriness to platelets has many causes other than alloimmunization. The application by Balducci et al. of accurate mathematical calculations makes their conclusions seem to be valid, but those calculations are based on a series of assumptions with little accuracy, some derived from limited data in the literature and some from local experience. If any of these assumptions are in error, the conclusions may not be warranted. Nevertheless, the Is white cell reduction cost-effective?